期刊文献+

选择性COX-2抑制剂抑制肺癌生长的实验研究 被引量:4

Experimental study on inhibitive effect of celecoxib on lung cancer
下载PDF
导出
摘要 目的:观察选择性环氧合酶-2(COX-2)抑制剂塞来昔布对肺癌A549细胞在体内外的抑制作用.方法:噻唑蓝(MTT)比色法检测塞来昔布对肺癌细胞的增殖抑制,流式细胞技术检测药物处理后A549的细胞周期,观察塞来昔布对裸鼠A549细胞移植瘤的抑制作用,移植瘤切片TUNEL法检测癌细胞凋亡.结果:塞来昔布对肺癌细胞增殖有抑制作用,IC50为50μmmol/L;阻滞G1期细胞进入S期.称量裸鼠移植肿瘤的瘤结节质量,对照组(2.16±0.98)g,药物组(0.98±0.51)g,两组差异有统计学意义(P<0.05),抑瘤率为54.6%.TUNEL法移植瘤切片凋亡细胞染色对照组凋亡指数(AI)为1.6±0.6,用药组为9.5±2.5,差异有统计学意义(P<0.05).结论:塞来昔布在体内及体外均对肺癌细胞表现有抑制作用,将细胞周期阻滞在G1期并诱导肿瘤细胞凋亡可能是抑制肺癌细胞增殖的重要机制. AIM: To observe the inhibitive effect of celecoxib, a selective inhibitor of cyclooxygenasc-2 ( COX-2 ), in vitro and in vivo, on the proliferation of A549 cell line. METHODS: Antiproliferative effect was detected by MTT assay and flow cytometry was used to analyze the effect of celecoxib on cell cycles. Nude mice bearing lung cancer xenografts were treated with celecoxib and then the weight of implanted tumors was measured. The apoptotic cells in implanted tumors were stained by terminal deoxynucleotidyl transferasemediated dUTP nick-end labeling (TUNEL) technique. RESULTS : Celecoxib inhibited the cell proliferation of lung cancer cells in a dose-dependent manner and IC50 was 50 umoL/L. Celecoxib induced the cycle arrest at G0/G1 stage, inhibiting the transition of G1 cells to S phrase. The average weight of tumor nodules in control group was (2.16 ± 0.98 ) g, while in the experimental group the average weight was (0.98 ±0.51 )g, with the inhibitive rate of 54.6% (P 〈 0.05). Apoptosis of tumor cells showed that apoptotic index (AI) was 1.6±0.6 in the control group and 9.5±2.5 in the experimental group, with significant differences (P 〈 0. 05 ). CONCLUSION: Celecoxib may exert its suppressive effect in vitro and in vivo on the proliferation of A549 cell line by inducing cell cycle arrest at G0-G1 stage of A549 cell and apoptosis of the tumor cells.
出处 《第四军医大学学报》 北大核心 2009年第16期1472-1475,共4页 Journal of the Fourth Military Medical University
关键词 肺肿瘤 环氧合酶-2 塞来昔布 细胞周期 细胞凋亡 lung neoplasms cyclooxygenase-2 celecoxib cell cycle apoptosis
  • 相关文献

参考文献12

  • 1Khuri FR, Wu H, Lee JJ, et al. Cycloxygenase-2 overexpression is a marker of poor prognosis in stage Ⅰ non-small cell lung cancer [ J]. Clin Cancer Res, 2001,7(4) : 861 -867.
  • 2Laga AC, Zander DS, Cagle PT, et al. Prognostic significance of cyclooxygenase-2 expression in 259 cases of non-small cell lung cancer [J]. Arch Pathol Lab Med, 2005,129(9) :1113 -1117.
  • 3Arber N. Cyclooxygenase-2 inhibitors in colorectal cancer prevention : point [ J]. Cancer Epidemiol Biomarkers Prev,2008, 17 (8) : 1852 - 1857.
  • 4Takkouche B, Regueira-Mendez C, Etminan M,et al. Breast cancer and use of nonsteroidal anti-inflammatory drugs: A meta-analysis [J]. J Natl Cancer Inst,2008,100(20) :1439 - 1447.
  • 5Harris RE, Beebe-Donk J, Schuller HM,et al. Chemoprevention of lung cancer by non-steroidal inflammatory drugs among cigarette smokers [ J]. Oncol Rep, 2002,9 (4) :693 - 695.
  • 6Kisley LR, Barrett BS, Dwye.r-NJeld LD, et al. Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice [ J ]. Carcinogenesis,2002,23(10) :1653 - 1660.
  • 7Hida T, Kozaki K, Muramatsu H, et al. Cyclooxygenase (COX)-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines [ J ]. Clin Cancer Res, 2000,6 ( 5 ) :2006 - 2011.
  • 8Tsubouchi Y, Mukai S, Kawahito Y, et al. Meloxicam inhibits the growth of non-small cell lung cancer [ J]. Anticancer Res, 2000, 20(5A) :2867 -2872.
  • 9Costanzo AD, Robert DB, Eric MS, et al. Cyclooxygenase-2 inhibition decrease primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma [ J ]. J Thorac Cardiovasc Surg,2003,126(4) :1129 - 1133.
  • 10徐美虹,吴开春,吴汉平,幺立萍,樊代明.非甾体类抗炎药对胃癌细胞增殖的抑制作用[J].中华消化杂志,2002,22(4):199-201. 被引量:20

二级参考文献3

共引文献19

同被引文献47

  • 1王亚丽,牟晓燕,白小燕,马春燕,范智彦.吉非替尼联合塞来昔布对肺腺癌细胞凋亡和EGFR、COX-2表达的影响[J].山东大学学报(医学版),2009,47(8):37-41. 被引量:6
  • 2Ning-Bo Liu,Tao Peng,Chao Pan,Yu-Yu Yao,Bo Shen,Jing Leng.Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis[J].World Journal of Gastroenterology,2005,11(40):6281-6287. 被引量:20
  • 3亓玉琴,司君利,魏涛,贺远龙,李文利,朱菊人.环氧化酶-2抑制剂塞来昔布对胃癌端粒酶活性影响的体内外实验研究[J].实用癌症杂志,2006,21(2):113-116. 被引量:5
  • 4Julie G, Jaffer A. Thinking in and out of the box when it comes to gastric cancer and cyclooxygenase- 2. J Clin Oncol,2007,25 (31):4865.
  • 5Han C, Michalopoulos G K, Wu T. Prostaglandin E2 receptor EP1 trans - activates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. Cell Physiol,2006, 207(1) : 261.
  • 6Huang L,Wang C ,Zheng W,et al. Effects of celeeoxib on the reversal of mutidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P -glycoprotein. Anticancer Drugs,2007, 18 (9) :1075.
  • 7Zhang X, Chen Z, Choe M S, et al. Tumor growth inhibition by simeltaneously blocking Epidermal Growth Factor Receptor and cyclooxygenase - 2 in a xenograft model. Clin Cancer Res , 2005,11 ( 17 ) :6261.
  • 8Mao jT, Roth MD, Fishbein MC, et al. Lung cancer chemopreven- tion with celecoxib in former smokers [ J ]. Cancer Prey Res ( Phi- la) ,2011, 4(7) :984 -93.
  • 9Zhang M,Xu ZG,Shi Z,et al. Inhibitory effect of celecoxib in lung carcinoma by regulation of cyclooxygenase-2/cytosolic phospholipase A and peroxisome proliferator-activated receptor gamma [ J ]. Mol Cell Biochem ,2011,355 ( 1 - 2 ) :233 - 240.
  • 10Park W, Oh YT, Han JH, et al. Antitumor enhancement of celecox- ib, a selective Cyclooxygenase-2 inhibitor,in a Lewis lung carcinoma expressing Cyc|ooxygenase-2 [ J ]. J Exp Clin Cancer Res,2008 27:66 - 69.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部